← Back to Search

Biological

Platelet Rich Plasma Eye Drops for Treatment of Ocular Surface Disease

Phase 4
Waitlist Available
Research Sponsored by University Health Network, Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at 6 and 12 weeks visit
Awards & highlights
Drug Has Already Been Approved
Pivotal Trial
No Placebo-Only Group

Summary

This trial is testing eye drops made from a patient's own blood to treat severe eye surface disease. It targets patients who don't respond well to standard treatments. The drops help heal the eye by providing essential growth factors and anti-inflammatory substances. These eye drops have been shown to be effective for the treatment of many eye diseases.

Eligible Conditions
  • Dry Eye Syndrome
  • Dry Eye

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at 6 and 12 weeks visit
This trial's timeline: 3 weeks for screening, Varies for treatment, and at 6 and 12 weeks visit for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Mean change from baseline in Ocular Surface Disease Index (OSDI) score questionnaire
Secondary study objectives
Mean change from baseline of Corneo-conjunctival staining score

Awards & Highlights

Drug Has Already Been Approved
The FDA has already approved this drug, and is just seeking more data.
Pivotal Trial
The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Treatment groupExperimental Treatment1 Intervention
Participant with moderate to sever ocular surface disease will be treated with autologous platelet rich plasma eye drops

Find a Location

Who is running the clinical trial?

University Health Network, TorontoLead Sponsor
1,527 Previous Clinical Trials
503,446 Total Patients Enrolled
~20 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top